Skip to main content
letter
. 2017 Jun 16;31(9):1987–1989. doi: 10.1038/leu.2017.156

Figure 1.

Figure 1

Individual dose-normalized pomalidomide concentration vs time profiles: healthy normal participants vs patients with MM3.